Ginsenoside Rb1 stabilized and paclitaxel / protopanaxadiol co-loaded nanoparticles for synergistic treatment of breast tumor.

[1]  Yifei Guo,et al.  Improved Therapeutic Efficacy of CBD with Good Tolerance in the Treatment of Breast Cancer through Nanoencapsulation and in Combination with 20(S)-Protopanaxadiol (PPD) , 2022, Pharmaceutics.

[2]  Xiaoqing Yi,et al.  Recent Advances in Stimuli-Sensitive Amphiphilic Polymer-Paclitaxel Prodrugs , 2022, Frontiers in Bioengineering and Biotechnology.

[3]  S. Mitragotri,et al.  Strategies to improve the EPR effect: A mechanistic perspective and clinical translation. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Xudong Fan,et al.  Cooperative coordination-mediated multi-component self-assembly of “all-in-one” nanospike theranostic nano-platform for MRI-guided synergistic therapy against breast cancer , 2022, Acta pharmaceutica Sinica. B.

[5]  Kunqian Yu,et al.  Versatile ginsenoside Rg3 liposomes inhibit tumor metastasis by capturing circulating tumor cells and destroying metastatic niches , 2022, Science advances.

[6]  H. Ren,et al.  Effect of the structure of ginsenosides on the in vivo fate of their liposomes , 2022, Asian journal of pharmaceutical sciences.

[7]  Qingchao Liu,et al.  Insight on structural modification, biological activity, structure-activity relationship of PPD-type ginsenoside derivatives. , 2022, Fitoterapia.

[8]  Xueting Cai,et al.  Ginseng-derived nanoparticles potentiate immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment. , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  Young-Su Yi.  New mechanisms of ginseng saponin-mediated anti-inflammatory action via targeting canonical inflammasome signaling pathways. , 2021, Journal of ethnopharmacology.

[10]  Nicholas A. Peppas,et al.  Engineering precision nanoparticles for drug delivery , 2020, Nature reviews. Drug discovery.

[11]  Hui Zheng,et al.  Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases: Pharmacology and mechanisms. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  Xingli Fu,et al.  Moxibustion Enhances Chemotherapy of Breast Cancer by Affecting Tumor Microenvironment , 2020, Cancer management and research.

[13]  Xiaoyuan Chen,et al.  The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy , 2020, Theranostics.

[14]  Yifei Guo,et al.  Soybean lecithin stabilizes disulfiram nanosuspensions with a high drug-loading content: remarkably improved antitumor efficacy , 2020, Journal of Nanobiotechnology.

[15]  Yeonseok Chung,et al.  A Critical Regulation of Th17 Cell Responses and Autoimmune Neuro-Inflammation by Ginsenoside Rg3 , 2020, Biomolecules.

[16]  Jordan J. Green,et al.  Nonviral polymeric nanoparticles for gene therapy in pediatric CNS malignancies. , 2020, Nanomedicine : nanotechnology, biology, and medicine.

[17]  Zijun Zhang,et al.  Ginsenoside Rh2 reverses cyclophosphamide‐induced immune deficiency by regulating fatty acid metabolism , 2019, Journal of leukocyte biology.

[18]  Lian‐Wen Qi,et al.  Inactivation of NF-κB2 (p52) restrains hepatic glucagon response via preserving PDE4B induction , 2019, Nature Communications.

[19]  Jing Qin,et al.  Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer , 2019, Theranostics.

[20]  S. Almahmoud,et al.  Conformational Studies of Glucose Transporter 1 (GLUT1) as an Anticancer Drug Target , 2019, Molecules.

[21]  Xiaofeng Yu,et al.  20(S)-Protopanaxadiol Inhibits Angiotensin II-Induced Epithelial- Mesenchymal Transition by Downregulating SIRT1 , 2019, Front. Pharmacol..

[22]  T. Osaki,et al.  A Basic Study of Photodynamic Therapy with Glucose-Conjugated Chlorin e6 Using Mammary Carcinoma Xenografts , 2019, Cancers.

[23]  Hui Wang,et al.  Novel ultra-small micelles based on ginsenoside Rb1: a potential nanoplatform for ocular drug delivery , 2019, Drug delivery.

[24]  Li Li,et al.  Co-delivery of doxorubicin and itraconazole by Pluronic® P123 coated liposomes to enhance the anticancer effect in breast cancers , 2018, RSC advances.

[25]  Hui Ma,et al.  Cellular stress response mechanisms as therapeutic targets of ginsenosides , 2018, Medicinal research reviews.

[26]  Jiandu Lei,et al.  “Nano-Ginseng” for Enhanced Cytotoxicity AGAINST Cancer Cells , 2018, International journal of molecular sciences.

[27]  C. Mancuso,et al.  Panax ginseng and Panax quinquefolius: From pharmacology to toxicology , 2017, Food and Chemical Toxicology.

[28]  Lian‐Wen Qi,et al.  Ginsenoside Rg5 attenuates hepatic glucagon response via suppression of succinate-associated HIF-1α induction in HFD-fed mice , 2017, Diabetologia.

[29]  S. Davaran,et al.  Liposome-based drug co-delivery systems in cancer cells. , 2017, Materials science & engineering. C, Materials for biological applications.

[30]  Wei Zhang,et al.  Prospective Study of Transcatheter Arterial Chemoembolization (TACE) with Ginsenoside Rg3 versus TACE Alone for the Treatment of Patients with Advanced Hepatocellular Carcinoma. , 2016, Radiology.

[31]  Jiandu Lei,et al.  Ginsenoside nanoparticle: a new green drug delivery system. , 2016, Journal of materials chemistry. B.

[32]  Wei-dong Yang,et al.  Propranolol Inhibits Glucose Metabolism and 18F-FDG Uptake of Breast Cancer Through Posttranscriptional Downregulation of Hexokinase-2 , 2014, The Journal of Nuclear Medicine.

[33]  Rui Zhang,et al.  20(S)-protopanaxadiol triggers mitochondrial-mediated apoptosis in human lung adenocarcinoma A549 cells via inhibiting the PI3K/Akt signaling pathway. , 2013, The American journal of Chinese medicine.

[34]  Xiaofeng Yu,et al.  Beneficial effects of 20(S)-protopanaxadiol on antitumor activity and toxicity of cyclophosphamide in tumor-bearing mice , 2012, Experimental and therapeutic medicine.

[35]  H. Sasaki,et al.  Overexpression of GLUT1 correlates with Kras mutations in lung carcinomas. , 2011, Molecular medicine reports.

[36]  Yong Cheng,et al.  Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action , 2005, Acta Pharmacologica Sinica.

[37]  R. Shigemoto,et al.  Distribution of the glucose transporters in human brain tumors. , 1992, Cancer research.

[38]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.